Dr. Vahideh Mohammadzadeh, mashhad university of medical science, Iran
Dr. Vahideh Mohammadzadeh is a Ph.D. student in Pharmaceutical Nanotechnology at Mashhad University of Medical Sciences, Iran. Her research focuses on innovative drug delivery systems like nanoliposomes for treating cancer and eye diseases. With expertise in nanoformulations (liposome, micelle, polymer), she conducts in-vitro assays and specializes in MTT assay and HPLC. Her work spans biochemistry, immunology, and nanomedicine, highlighted by numerous publications on nanosensors, therapeutic nanoparticles, and drug delivery advancements. Dr. Mohammadzadeh is also skilled in statistical analysis, technical writing, and communication. She aims to revolutionize healthcare through cutting-edge pharmaceutical nanotechnology. 📚💊
Professional Background
Dr. Vahideh Mohammadzadeh is currently pursuing her Ph.D. in Pharmaceutical Nanotechnology at Mashhad University of Medical Sciences, Iran. Her research primarily focuses on advancing drug delivery systems, particularly through nanotechnology. She specializes in the formulation of nanoliposomes and other nanostructures like micelles and polymers for targeted therapy in cancer and ocular diseases. Dr. Mohammadzadeh has extensive experience in conducting in-vitro biochemical and immunological assays, including MTT assay and HPLC analysis. Her work is underscored by a prolific publication record encompassing topics such as nanosensors, therapeutic nanoparticles, and innovative drug formulations. 📊🔬
Education
Ph.D., Pharmaceutical Nanotechnology, Mashhad University of Medical Sciences, 2018-2024
M.Sc., Toxicology, Mashhad University of Medical Sciences, 2014-2017
B.Sc., Biology
Research Focus
Dr. Vahideh Mohammadzadeh’s research primarily focuses on advancing drug delivery systems in cancer therapy through innovative nanotechnologies. Her work spans the development and characterization of nanoliposomes, polymeric micelles, and other nanostructures to enhance the targeted delivery of therapeutic agents for cancer and ocular diseases. She explores novel formulations like liposomes and plant-based nanoparticles to optimize drug efficacy while minimizing side effects. Dr. Mohammadzadeh’s research also delves into nanosensors for biomolecule detection and the biological synthesis of nanoparticles for cytotoxicity studies. Her contributions aim to revolutionize healthcare through cutting-edge nanomedicine solutions. 🌟🔬
Publication Top Notes
- Poly-γ-glutamic acid nanoparticles as adjuvant and antigen carrier system for cancer vaccination 📄 Citations: 14 | Cited by: Jaafari, M.R. et al. | Year: 2023
- Plant Gel-Mediated Synthesis of Gold-Coated Nanoceria Using Ferula gummosa: Characterization and Estimation of Its Cellular Toxicity toward Breast Cancer Cell Lines 📄 Citations: 14 | Cited by: Sarafraz Ardakani, M.R. et al. | Year: 2023
- Icariin: A Promising Natural Product in Biomedicine and Tissue Engineering 📄 Citations: 22 | Cited by: Simal-Gandara, J. et al. | Year: 2023
- Correction to: New insights into the application of nanoghosts as theranostic tools with an emphasis on cardiovascular diseases 📄 Citations: 1 | Cited by: Qindeel, M. et al. | Year: 2022
- Novel EPR-enhanced strategies for targeted drug delivery in pancreatic cancer: An update 📄 Citations: 21 | Cited by: Sibuh, B.Z. et al. | Year: 2022
- Fluorescent-based nanosensors for selective detection of a wide range of biological macromolecules: A comprehensive review 📄 Citations: 106 | Cited by: DÃez-Pascual, A.M. et al. | Year: 2022
- Applications of plant-based nanoparticles in nanomedicine: A review 📄 Citations: 84 | Cited by: Varma, R.S. et al. | Year: 2022
- Biological synthesis and characterization of gold nanoparticles using Verbascum speciosum Schrad. and cytotoxicity properties toward HepG2 cancer cell line 📄 Citations: 35 | Cited by: Nadaf, M. et al. | Year: 2022
- Theranostic advances of bionanomaterials against gestational diabetes mellitus: A preliminary review 📄 Citations: 24 | Cited by: Thakur, V.K. et al. | Year: 2021